DarioHealth Corp. Warrant
DRIOW
DRIOW was delisted on the 4th of March, 2021.
2 hedge funds and large institutions have $11K invested in DarioHealth Corp. Warrant in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
10% more capital invested
Capital invested by funds: $10K → $11K (+$1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
+$12.8K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $9K | +$12.8K | +66,389 | New |
|
2
UBS Group
Zurich,
Switzerland
| $2K | – | – | – |
|
DRIOW Hedge Fund Activity: Q3 2018 in Review
2 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q3 2018, worth a combined $11K — up 10% from $10K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new DRIOW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bard Associates, opening a new position worth an estimated $12.8K.
- 2 institutional investors held DarioHealth Corp. Warrant (DRIOW) as of Q3 2018, up from 1 in Q2 2018.
- Funds reported $11K of DarioHealth Corp. Warrant stock for Q3 2018, up 10% quarter-over-quarter.
- 1 fund opened new DarioHealth Corp. Warrant positions in Q3 2018 and 0 closed out, a net change of +1 holder.
- The largest DarioHealth Corp. Warrant buyer in Q3 2018 was Bard Associates, an estimated $12.8K added.
Based on aggregated 13F filings for Q3 2018.